Does the time of day of immunotherapy infusions affect patients’ survival outcomes? A recent meta-analysis that examined data from over a dozen studies concluded that immunotherapy provided earlier in the day substantially improves progression-free and overall survival across a range of cancers, including metastatic melanoma, renal cell carcinoma…
Read More